Role of Peroxisome Proliferator-Activated Receptor γ and Its Ligands in Non-Neoplastic and Neoplastic Human Urothelial Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Role of Peroxisome Proliferator-Activated Receptor γ and Its Ligands in Non-Neoplastic and Neoplastic Human Urothelial Cells

Published:2001-08 Issue:2 Volume:159 Page:591-597
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Nakashiro Koh-ichi,Hayashi Yoshiki,Kita Akiyo,Tamatani Tetsuya,Chlenski Alexandre,Usuda Nobuteru,Hattori Kazunori,Reddy Janardan K.,Oyasu Ryoichi

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference28 articles.

1. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver;Zhu;J Biol Chem,1993

2. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor;Tontonoz;Cell,1994

3. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors;Kliewer;Proc Natl Acad Sci USA,1994

4. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rats;Braissant;Endocrinology,1996

5. Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans;Guan;Am J Physiol,1997

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Duality of the SVIL expression in bladder cancer and its correlation with immune infiltration;Scientific Reports;2023-09-05

2. Pioglitazone, Bladder Cancer, and the Presumption of Innocence;Current Drug Safety;2022-11

3. Overexpression of the PPAR‑γ protein in primary Ta/T1 non‑muscle‑invasive urothelial carcinoma;Molecular and Clinical Oncology;2021-12-16

4. Increased DNA strand breaks and neoplastic transformation in human bladder cells treated with pioglitazone;Environmental and Molecular Mutagenesis;2021-02

5. Retinoic acid signaling and bladder cancer: Epigenetic deregulation, therapy and beyond;International Journal of Cancer;2020-11-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3